Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.60 |
| ▸ | RXFP1 | Q9HBX9 | 3/20 | 0.59 |
| ▸ | KCNK3 | O14649 | 2/20 | 0.54 |
| ▸ | KCNK9 | Q9NPC2 | 2/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | PTPRC | P08575 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | EPHB3 | P54753 | 1/20 | 0.48 |
| ▸ | F2R | P25116 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27582898 | 0.84 | LMNA (0.67) | SMN1; SMN2LMNAGAARXFP1KCNK3 | |
| SCHEMBL13477980 | 0.83 | SMN1; SMN2 (0.60) | SMN1; SMN2LMNAGAARXFP1KCNK3 | |
| SCHEMBL21311188 | 0.83 | HTT (0.62) | SMN1; SMN2LMNAGAARXFP1KCNK3 | |
| SCHEMBL12918684 | 0.83 | SMN1; SMN2 (0.64) | SMN1; SMN2LMNAGAARXFP1KCNK3 | |
| SCHEMBL2936256 | 0.83 | SMN1; SMN2 (0.78) | SMN1; SMN2LMNAGAARXFP1KCNK3 | |
| SCHEMBL26066184 | 0.80 | SMN1; SMN2 (0.57) | SMN1; SMN2LMNAGAARXFP1KCNK3 | |
| SCHEMBL16371758 | 0.80 | LMNA (0.55) | SMN1; SMN2LMNAGAARXFP1KCNK3 | |
| SCHEMBL21311187 | 0.79 | SMN1; SMN2 (0.56) | SMN1; SMN2LMNAGAARXFP1KCNK3 | |
| SCHEMBL15925029 | 0.79 | RXFP1 (0.57) | SMN1; SMN2LMNAGAARXFP1KCNK3 | |
| SCHEMBL2937452 | 0.79 | SMN1; SMN2 (0.56) | SMN1; SMN2LMNAGAARXFP1KCNK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1480516-B1 | MICROBICIDAL AGENTS ON THE BASIS OF BIPHENYL BENZAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2010-02-03 | — | — | EP | disclosed |
| EP-1480516-B1 | MICROBICIDAL AGENTS ON THE BASIS OF BIPHENYL BENZAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2010-02-03 | — | — | EP | disclosed |
| US-7186862-B2 | Microbicidal agents on the basis of biphenylbenzamide derivatives | BAYER CROPSCIENCE AG (DE) | 2007-03-06 | — | — | US | disclosed |
| US-7186862-B2 | Microbicidal agents on the basis of biphenylbenzamide derivatives | BAYER CROPSCIENCE AG (DE) | 2007-03-06 | — | — | US | disclosed |
| US-7186862-B2 | Microbicidal agents on the basis of biphenylbenzamide derivatives | BAYER CROPSCIENCE AG (DE) | 2007-03-06 | — | — | US | disclosed |
| CN-1845673-A | Pyridylacanilides | BAYER CROPSCIENCE AG (DE) | 2006-10-11 | — | — | CN | disclosed |
| EP-1656020-A2 | PYRIDINYLANILIDES | Bayer CropScience AG (DE) | 2006-05-17 | — | — | EP | disclosed |
| US-20050119347-A1 | Microbicidal agents on the basis of biphenyl benzamide derivatives | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2005-06-02 | — | — | US | disclosed |
| WO-2005004606-A2 | PYRIDINYLANILIDES | BAYER CROPSCIENCE AG (DE) | 2005-01-20 | — | — | WO | disclosed |
| EP-1480516-A1 | MICROBICIDAL AGENTS ON THE BASIS OF BIPHENYL BENZAMIDE DERIVATIVES | Bayer CropScience AG (DE) | 2004-12-01 | — | — | EP | disclosed |
| WO-2003069995-A1 | MICROBICIDAL AGENTS ON THE BASIS OF BIPHENYL BENZAMIDE DERIVATIVES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2003-08-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050119347-A1 | Microbicidal agents on the basis of biphenyl benzamide derivatives | DDT, MSR1, CYP1B1 | SMN1; SMN2 3753/4885LMNA 4173/4885GAA 1471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.